The SVP & CFO of Neurometrix (NASDAQ: NURO) is Buying Shares

By Carrie Williams

Today, the SVP & CFO of Neurometrix (NASDAQ: NURO), Thomas T. Higgins, bought shares of NURO for $3,020.

Following this transaction Thomas T. Higgins’ holding in the company was increased by 9.54% to a total of $35.82K. In addition to Thomas T. Higgins, 3 other NURO executives reported Buy trades in the last month.

Based on Neurometrix’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $3.55 million and GAAP net loss of $3.51 million. In comparison, last year the company earned revenue of $3.39 million and had a GAAP net loss of $3.91 million. The company has a one-year high of $9.60 and a one-year low of $1.45. Currently, Neurometrix has an average volume of 141K.

Starting in February 2012, NURO received 15 Buy ratings in a row.

The insider sentiment on Neurometrix has been positive according to 11 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

NeuroMetrix, Inc. engages in the research, development and trade of medical equipment and consumables. It offers wearable pain reliefs patch, advance ncs system, dpncheck and pain management device to treat chronic pain, nerve diseases and sleep disorder. The company was founded by Shai N. Gozani in June 1996 and is headquartered in Waltham, MA.